AGILENT TECHNOLOGIES, INC. A
Laboratory Analytical Instruments · NYSE
Revenue
$6.83B
-0.2% YoY
Net income
$1.24B
-1.1% YoY
Total assets
$11.85B
+10.1% YoY
EPS
4.19
+0.2% YoY
Advertisement
Income Statement
| Period | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Revenues | $5.09B | $3.35B | $1.68B | $6.83B | $4.81B | $3.23B | $1.66B | $6.85B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| R&D Expense | $336.00M | $225.00M | $113.00M | $481.00M | $368.00M | $241.00M | $128.00M | $467.00M |
| SG&A Expense | $1.28B | $864.00M | $410.00M | $1.63B | $1.17B | $776.00M | $396.00M | $1.64B |
| Operating Income (Loss) | $1.04B | $676.00M | $376.00M | $1.35B | $1.08B | $747.00M | $384.00M | $1.62B |
| Interest Expense | $85.00M | $57.00M | $28.00M | $95.00M | $64.00M | $42.00M | $22.00M | $84.00M |
| Net Income (Loss) | $869.00M | $533.00M | $318.00M | $1.24B | $938.00M | $656.00M | $348.00M | $1.25B |
| EPS (Diluted) | 3.05 | 1.86 | 1.11 | 4.19 | 3.20 | 2.23 | 1.18 | 4.18 |
Balance Sheet
| Period | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.73B | $12.73B | $12.73B | $11.85B | $11.85B | $11.85B | $11.85B | $10.76B |
| Current Assets | $4.59B | $4.59B | $4.59B | $3.96B | $3.96B | $3.96B | $3.96B | $4.19B |
| Cash & Equivalents | $1.79B | $1.79B | $1.79B | $1.59B | $1.33B | $1.33B | $1.33B | $1.05B |
| Accounts Receivable | $1.49B | $1.49B | $1.49B | $1.32B | $1.32B | $1.32B | $1.32B | $1.29B |
| Inventory | $1.02B | $1.02B | $1.02B | $972.00M | $972.00M | $972.00M | $972.00M | $1.03B |
| PP&E (Net) | $2.02B | $2.02B | $2.02B | $1.78B | $1.78B | $1.78B | $1.78B | $1.27B |
| Goodwill | $4.47B | $4.47B | $4.47B | $3.96B | $4.48B | $4.48B | $4.48B | $3.95B |
| Total Liabilities | $5.99B | $5.99B | $5.99B | $5.95B | $5.95B | $5.95B | $5.95B | $4.92B |
| Current Liabilities | $2.35B | $2.35B | $2.35B | $1.90B | $1.90B | $1.90B | $1.90B | $1.60B |
| Accounts Payable | $570.00M | $570.00M | $570.00M | $540.00M | $540.00M | $540.00M | $540.00M | $418.00M |
| Long-Term Debt | $3.05B | $3.05B | $3.05B | $3.35B | $3.35B | $3.35B | $3.35B | $2.73B |
| Stockholders Equity | $6.74B | $6.74B | $6.74B | $5.90B | $5.90B | $5.90B | $5.90B | $5.84B |
Cash Flow Statement
| Period | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.01B | $652.00M | $431.00M | $1.77B | $1.27B | $818.00M | $485.00M | $1.31B |
| Investing Cash Flow | $-304.00M | $-208.00M | $-94.00M | $-310.00M | $-304.00M | $-204.00M | $-95.00M | $-338.00M |
| Financing Cash Flow | $-515.00M | $-296.00M | $-180.00M | $-930.00M | $-777.00M | $-531.00M | $-240.00M | $-1.37B |
| Stock Repurchases | $340.00M | $255.00M | $90.00M | $575.00M | $815.00M | $230.00M | $0 | $1.14B |
Similar companies
Learn more
How to Find Any SEC Filing in Two MinutesCash-Flow Quality: Profit Is an Opinion, Cash Is a FactValuation Basics: P/E, P/S and What They Actually Tell YouDividends: How Companies Pay Shareholders and How to Read ThemHow to Read a 10-K Annual Report (Without Falling Asleep)Understanding Earnings Per Share (EPS)How to Read a Cash Flow StatementHow to Read a Balance SheetHow to Read an Income Statement
Data is sourced from the U.S. SEC EDGAR public database. This site does not provide investment advice.